MedTrace Logo

Addition of Zinc to the Current Case Management Package of Diarrhea in a Primary Health Care Setting

NCT00278746 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20032

Last updated 2015-06-16

No results posted yet for this study

Summary

Several studies have shown the beneficial effect of zinc treatment in acute diarrhea. There was a significant reduction in duration of the treated episodes and in their severity as measured by diarrheal stool output or frequency. Zinc is a potentially important immunomodulator or nutraceutical which may have great impact as therapeutic agent in conditions like diarrhea and pneumonia. The issue is whether and how zinc should be introduced in primary health care programs for treatment of acute diarrhea. A practical, sustainable intervention for introduction of zinc as treatment of acute diarrhoea in national programs is therefore required. This study aimed to address this issue.

Conditions

Interventions

DRUG

Zinc and ORS

Government and private providers and village health workers were trained to prescribe zinc and ORS for use in diarrheal episodes in 1 month to 5 years old children in intervention communities

DRUG

ORS only

Promoted routine management of diarrhea in underfive with ORS

Sponsors & Collaborators

  • Ministry of Science and Technology, India

    collaborator OTHER_GOV

  • United Nations Children's Fund, Delhi

    collaborator UNKNOWN

  • World Health Organization

    collaborator OTHER

  • Society for Applied Studies

    lead OTHER

Principal Investigators

  • Nita Bhandari, PhD · Society for Applied Studies

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Month
Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2006-09-30
Completion
2006-09-30

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00278746 on ClinicalTrials.gov